Developing a business case for a Myeloma Clinical Nurse Specialist

A practical resource to help healthcare professionals build a robust, well-evidenced business case for a Myeloma Clinical Nurse Specialist (CNS) post. It includes guidance on making the case for change, gathering evidence, aligning with local and national priorities, assessing costs and benefits, and planning how success will be measured.

If you are developing a case for a new or additional myeloma clinical nurse specialist (CNS) post, this guide is designed to support that process. Although the resource is focused on myeloma, many of the principles may also be useful when developing a business case for a haematology CNS post.

It sets out a clear structure for building a strong business case within your Trust or Health Board. The resource explains what information to include, which stakeholders to involve, what evidence to gather, and how to show both the clinical and organisational value of the role. It also highlights how a myeloma CNS post can support patient experience, service performance, and compliance with relevant standards and guidance.

What this guide covers

• Practical advice on gathering evidence and engaging the right stakeholders. 
• Guidance on showing service demand, unmet need, and the case for change. 
• Support with setting out costs, efficiencies, and potential savings. 
• Sample appendices, including a job description and CNS team job plan. 

Who this resource is for

This resource may be useful for consultant haematologists, clinical nurse specialists, lead nurses, service managers, and others involved in workforce planning or service development in myeloma and wider haematology services.